Etanercept plus Standard Therapy for Wegener's Granulomatosis
Top Cited Papers
Open Access
- 27 January 2005
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (4), 351-361
- https://doi.org/10.1056/nejmoa041884
Abstract
The majority of patients with Wegener's granulomatosis have disease flares after conventional medications are tapered. There is no consistently safe, effective treatment for the maintenance of remission.This publication has 29 references indexed in Scilit:
- Limited versus severe Wegener's granulomatosis: Baseline data on patients in the Wegener's granulomatosis etanercept trialArthritis & Rheumatism, 2003
- Design of the Wegener's Granulomatosis Etanercept Trial (WGET)Controlled Clinical Trials, 2002
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitidesArthritis & Rheumatism, 1997
- The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient GroupsMedical Care, 1994
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992
- Covariate adjustment of treatment effects in clinical trialsControlled Clinical Trials, 1991
- The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosisArthritis & Rheumatism, 1990
- Tests of Hypotheses in Overdispersed Poisson Regression and Other Quasi-Likelihood ModelsJournal of the American Statistical Association, 1990
- The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infectionCell, 1989